When the first weeks of motherhood feel nothing like they were supposed to — you are not alone, and this is treatable
Ketamine for postpartum depression Baltimore costs $499.99 per session ($375 for Vitality Circle members) and is an off-label IV infusion evaluated for PPD that hasn't responded adequately to FDA-approved PPD treatments, SSRIs, or therapy. Postpartum depression affects roughly 10–15% of mothers — about 1 in 7 — and is distinct from the baby blues, which fade within two weeks; persistent symptoms warrant prompt screening. Breastfeeding status is reviewed individually, in coordination with your OB/GYN and pediatrician — no blanket reassurance, no blanket exclusion. Ketamine's NMDA pathway is distinct from the neurosteroid treatments approved for PPD, which is why it is considered when those fall short. Every infusion is delivered as anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins anesthesiologist, with a Certified Registered Nurse Anesthetist (CRNA) on-site. Self-pay with an itemized superbill you can file with your insurance; not everyone is a candidate.
"The team is extremely professional, compassionate and knowledgeable — they take the time to explain the process thoroughly and care about your well-being throughout." — Google review, Vita Nova patient
Founder & Medical Director, Vita Nova · Johns Hopkins Faculty Physician · Assistant Professor, Anesthesiology & Critical Care Medicine · Chief, Thoracic Anesthesia, Johns Hopkins Hospital · Board-Certified Anesthesiologist
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton, Baltimore MD 21224
(443) 563-1059
Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.
Your information is confidential. A clinical team member follows up within 1 business day.
"If you're reading this page, you may be months into what was supposed to be one of the most joyful times of your life — and instead you feel absent, exhausted, or afraid of your own thoughts."
That is not weakness. That is not a sign that you are a bad mother. That is postpartum depression — and it is more common, more complex, and more treatable than most new parents are told. Approximately 1 in 7 new mothers develop PPD. It is a medical condition with a biological basis, not a reflection of how much you love your baby or how capable a mother you are. You deserve care that actually works.
Postpartum depression is a major depressive episode occurring during pregnancy or within 4 weeks of delivery — though in practice, symptoms commonly emerge and persist for months following childbirth. It is distinct from the transient "baby blues" in severity, duration, and the degree of functional impairment it causes. In its more severe forms it can include intrusive thoughts, thoughts of self-harm, and suicidal ideation — all of which require prompt clinical attention.
Postpartum depression is the one mental health condition on this site with FDA-approved treatments designed specifically for it. These should be your first clinical conversation — before ketamine is evaluated.
The first oral medication FDA-approved specifically for PPD. A 14-day neurosteroid treatment that rapidly restores GABA-A receptor tone depleted by postpartum progesterone withdrawal. Available by prescription from your OB/GYN or mental health prescriber.
IV synthetic allopregnanolone given as a 60-hour continuous inpatient infusion in a certified setting. Directly restores the neurosteroid that drops precipitously after delivery. Requires inpatient monitoring.
SSRIs (sertraline, escitalopram) are commonly prescribed for PPD with an established evidence base. Interpersonal therapy (IPT) and CBT are first-line psychological approaches with strong PPD-specific evidence.
Understanding why ketamine may be relevant to postpartum depression requires understanding the specific biology of PPD — which is distinct from the biology of standard major depression.
During pregnancy, progesterone rises dramatically and is converted to allopregnanolone — a neurosteroid that provides powerful inhibitory calming tone through GABA-A receptor modulation. After delivery, progesterone drops precipitously within 24–48 hours. Allopregnanolone falls with it — withdrawing the GABAergic calming effect the brain has adapted to over 9 months. This neurosteroid withdrawal is the primary biological trigger of postpartum depression for most affected women.
Brexanolone and zuranolone work by directly restoring allopregnanolone levels. For many women, this is highly effective. For others, neurosteroid restoration alone does not fully resolve the depression — because postpartum mood dysregulation involves more than one biological pathway. Chronic sleep deprivation, the metabolic demands of breastfeeding, inflammatory changes, and glutamatergic circuit stress can all contribute to persistent PPD beyond the neurosteroid component.
Ketamine targets a different pathway entirely — NMDA glutamate receptor blockade, rapid BDNF release, and synaptogenesis in prefrontal and limbic mood circuits. For patients whose PPD has not responded adequately to neurosteroid treatments or SSRIs, ketamine's glutamatergic mechanism may address the residual mood circuit dysfunction that the neurosteroid-targeting approach did not fully reach.
The speed of ketamine's antidepressant effect has particular clinical relevance in the postpartum period. A new mother who cannot be present for her baby needs relief as quickly as possible. The weeks required for SSRIs to show effect, or the 14-day zuranolone course, may feel impossibly long. Ketamine's potential to produce meaningful symptom reduction within hours to days is a distinct clinical advantage in this population.
The evidence base for ketamine specifically in postpartum depression is the earliest-stage of any condition evaluated at Vita Nova — based on prevention trials around cesarean delivery, case reports of established PPD, and mechanistic rationale. This is reflected in how the pathway is positioned — as an option for patients who have not responded to established first-line approaches.
Breastfeeding compatibility is the first question most mothers ask when ketamine is discussed for PPD. The answer is not a simple yes or no — and it is definitely not a blanket "stop breastfeeding." It is an individualized clinical conversation that your Vita Nova provider, your OB/GYN, and your pediatrician have together with you.
Ketamine passes into breast milk at low levels. The NIH LactMed database and a 2022 pharmacokinetic study that measured ketamine and its metabolite norketamine in breast milk both describe low milk concentrations that fall within hours as the drug is cleared. These data are small and observational — which is exactly why the decision is individualized rather than assumed.
Timing-based precautions are used clinically. Many clinicians recommend temporarily withholding breastfeeding for a defined period following each infusion — typically several hours, consistent with ketamine's roughly three-hour half-life — using expressed breast milk during that window.
Infant exposure data are limited. There are no large controlled studies examining ketamine exposure through breast milk in human infants. This uncertainty is part of the individualized risk-benefit conversation.
The risk-benefit calculation is yours to make — with support. The decision involves weighing the clinical benefit of effective PPD treatment against theoretical infant exposure during a limited window post-infusion. Neither untreated PPD nor brief ketamine exposure is without consequences.
Your Vita Nova provider coordinates with your OB/GYN and pediatrician. Breastfeeding timing guidance is discussed in detail during the clinical evaluation and coordinated with your existing care team. You do not have to navigate this decision alone.
Ketamine for postpartum depression is off-label. Ketamine at Vita Nova is self-pay — you pay directly, and we provide an itemized superbill you can file with your insurance. HSA and FSA cards are accepted for the full cost, and a member plan brings the per-session rate down. Every infusion is anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD, a Johns Hopkins faculty anesthesiologist in a private room with continuous monitoring — that physician-level care is what the per-session price reflects.
| Treatment | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine Infusion — per session Off-Label | $499.99 | $375 | $124.99/session |
| Complete Series — 6 infusions · includes 3 complimentary hydration IVs Off-Label | $2,849.94 | $2,250 | $599.94 |
Self-pay, with a superbill. Vita Nova is self-pay for ketamine. We provide an itemized superbill you can file with your insurance for possible out-of-network reimbursement. HSA and FSA accepted; Community Heroes discounts available. Pricing August 2026 — subject to change. Full pricing guide →
Pregnancy and the postpartum period deplete vitamin D, iron, B vitamins, and magnesium at rates that significantly affect mood, energy, and neurological function. Always discuss with your OB/GYN before beginning any supplemental therapy postpartum or while breastfeeding.
Vitamin D3 depletion is extremely common postpartum — particularly for breastfeeding mothers in Baltimore's northern latitude. D3 deficiency is strongly associated with mood disorders and fatigue.
✅ Included for Vitality Circle members (2 shots/month)Breastfeeding significantly increases B12 and folate demands — depletion contributes to fatigue, brain fog, and mood instability. IM delivery achieves immediate bioavailability.
✅ Included for Vitality Circle members (2 shots/month)Magnesium is depleted by pregnancy and new motherhood. Deficiency contributes to anxiety, sleep disruption, and muscle tension — all common PPD features. Modulates NMDA receptor sensitivity relevant to ketamine's mechanism.
✅ Included for Vitality Circle members (2 shots/month)Postpartum iron-deficiency anemia is a common contributor to PPD symptoms — fatigue, cognitive fog, and low mood. Iron is also a cofactor in dopamine and serotonin synthesis. IV iron achieves rapid repletion when oral iron is insufficient or poorly tolerated.
Members: 25% offImportant for postpartum patients: These wellness services are general offerings — not treatments for PPD. The appropriate doses and timing must be reviewed by your OB/GYN and pediatrician in the context of your specific breastfeeding situation before beginning supplemental therapy.
Postpartum depression does not discriminate by profession — but teachers, nurses, healthcare workers, and military spouses experience PPD under conditions of amplified stress. The Community Heroes program ensures that cost is not a barrier for those who give the most.
Common questions from new mothers and their families evaluating ketamine therapy for postpartum depression in Baltimore.
🆘 If you are experiencing thoughts of self-harm or suicidal ideation, call or text 988 (Suicide & Crisis Lifeline) now, or go to your nearest emergency room. For perinatal-specific support, the Postpartum Support International HelpLine is 1-800-944-4773, and the Maternal Mental Health Hotline is 1-833-852-6262.
FDA-approved PPD treatments explored first. Breastfeeding review included. No commitment required.
Book Consultation → View Self-Pay PricingWhen FDA-approved PPD treatments or SSRIs haven't been enough, a different mechanism may help. Breastfeeding compatibility is reviewed individually, care is coordinated with your full team, and all treatment is anesthesiologist-led, under the medical direction of Dr. Brijen Joshi MD. Self-pay with an itemized superbill you can file with your insurance. No commitment required.
📍 513 Bayview Blvd · Canton, Baltimore MD 21224 · 🅿️ Free Parking
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM · (443) 563-1059
Canonical URL: https://vitanovawellnessclinic.com/ketamine-postpartum-depression-baltimore/ · Last reviewed August 2026
Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic. · View full team →
Baltimore's physician-led clinic for Ketamine, IV vitamin infusions, Iron IV, and NAD+ therapy — serving our community with integrity and care.

Providing compliant, physician-led ketamine & IV therapy care — one of the few clinics certified in Maryland.
See Our Certification →Founded & directed by Dr. Brijen L. Joshi MD, Johns Hopkins School of Medicine faculty.
Meet Dr. Joshi →© 2026 Vita Nova Ketamine & Wellness Clinic. All Rights Reserved.
Disclaimer: All content and advertising on this website are provided for general informational purposes only and do not constitute medical advice, diagnosis, or treatment. Always consult with a licensed healthcare provider regarding your care.
Marketing Statement: No reviews or testimonials on this website have been incentivized, altered, or requested in exchange for compensation. Testimonials reflect individual experiences, and results may vary.
Certification Statement: Vita Nova Ketamine & Wellness Clinic is a LegitScript-certified treatment center. This website was built with compliance in mind to align with HIPAA and LegitScript content requirements.